EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabinoid Receptors Reduced Early Brain Damage by Regulating NOX‐2 and the NLRP3 Inflammasome in an Animal Model of Intracerebral Hemorrhage

Ari Misael Martínez-Torres, Crisalde Ramírez-Celis, Julio Morán iD

CNS Neuroscience & Therapeutics · 2025-04 · 31 (4)

DOI: 10.1111/cns.70385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 17.04.2025. Verfasst von Ari Misael Martínez-Torres und 2 weiteren Autor:innen. Beteiligte Einrichtung: División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, México. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Cerebral Hemorrhage, NADPH Oxidase 2, Inflammasomes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México, Consejo Nacional de Humanidades, Ciencias y Tecnologías.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intracerebral hemorrhage (ICH) is a leading cause of death and disability worldwide. Following the initial mechanical injury caused by hematoma expansion, a secondary injury occurs, characterized by the production of reactive oxygen species (ROS) generated by NOX‐2 and neuroinflammation, which is exacerbated by the upregulation of the NLRP3 inflammasome. These conditions collectively aggravate brain damage. The endocannabinoid system (ECS), through the activation of the cannabinoid receptors, has demonstrated neuroprotective properties in various models of brain injury. However, the role of the ECS during ICH remains poorly understood, particularly regarding the action of the CB1 receptor in the activation of NOX‐2 and the inflammasome. The present study investigates the neuroprotective effects of the cannabinoid receptor agonist WIN55,212‐2 in an ICH animal model, specifically examining the roles of NLRP3 and NOX‐2.

Methods

Male C57BL/6 mice were subjected to ICH through an intracerebral injection of collagenase, followed by intraperitoneal administration of WIN55,212‐2 and/or MCC950, a selective NLRP3 inhibitor. Various outcome measures were employed, including assessments of motor activity, hematoma volume, brain water content, and blood–brain barrier (BBB) permeability, which was evaluated using Evans blue assay. Additionally, the activity of NOX and the protein levels of crucial markers such as CB1, gp91phox, NLRP3, AQP4, and caspase‐1 were measured via western blot analysis.

Result

The findings demonstrate that ICH induced a significant brain lesion characterized by hematoma formation, edema, BBB disruption, and subsequent motor impairments in the affected mice. Notably, these detrimental effects were markedly reduced in animals treated with WIN55,212‐2. The study also revealed an activation of both NOX‐2 and NLRP3 in response to ICH, which was reduced by cannabinoid receptor activation. Furthermore, the pharmacological inhibition of NLRP3 using MCC950 also led to a reduction in hematoma size, edema, and motor impairment secondary to ICH.

Conclusions

These results support a neuroprotective role of the cannabinoid receptor activation during ICH and suggest the involvement of NOX‐2 and NLRP3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinCerebral HemorrhageNADPH Oxidase 2InflammasomesAnimalsMiceMaleBenzoxazinesMorpholinesMice, Inbred C57BLNaphthalenesDisease Models, AnimalCannabinoid Receptor AgonistsFuransIndenesSulfonamides

Stichwörter der Autor:innen

CB1 receptorcannabinoidsintracerebral hemorrhageneuroinflammationoxidative stress

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNADPH Oxidase 2(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneBenzoxazinesInflammasomesMorpholinesNlrp3 protein, mouseCybb protein, mouseNaphthalenesCannabinoid Receptor Agonists

Autor:innen und Institutionen

  • División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, México.

ORCID-Profile: Julio Morán

Förderung

  • Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
  • Consejo Nacional de Humanidades, Ciencias y Tecnologías

Zitieren

APA

Martínez-Torres, A. M., Ramírez-Celis, C., & Morán, J. (2025). Cannabinoid Receptors Reduced Early Brain Damage by Regulating NOX‐2 and the NLRP3 Inflammasome in an Animal Model of Intracerebral Hemorrhage. CNS Neuroscience & Therapeutics, 31(4). https://doi.org/10.1111/cns.70385

Vancouver

Martínez-Torres AM, Ramírez-Celis C, Morán J. Cannabinoid Receptors Reduced Early Brain Damage by Regulating NOX‐2 and the NLRP3 Inflammasome in an Animal Model of Intracerebral Hemorrhage. CNS Neuroscience & Therapeutics. 2025;31(4). doi:10.1111/cns.70385

BibTeX
@article{MartnezTorres2025,
  author = {Martínez-Torres, Ari Misael and Ramírez-Celis, Crisalde and Morán, Julio},
  title = {Cannabinoid Receptors Reduced Early Brain Damage by Regulating NOX‐2 and the NLRP3 Inflammasome in an Animal Model of Intracerebral Hemorrhage},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  volume = {31},
  number = {4},
  doi = {10.1111/cns.70385}
}
Kostenlos starten →